Pasithea Therapeutics Corp's total assets for Q were $22.41M, a decrease of -14.20% from the previous quarter. KTTA total liabilities were $2.52M for the fiscal quarter, a -7.13% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.